ENG/中
老虎证券
行情
交易
收费
下载
优惠与活动
帮助
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
股权激励
关于
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Vivos Inc.
0.0880
-0.0020
-2.22%
成交量:
18.99万
成交额:
1.67万
市值:
4,001.05万
市盈率:
-12.76
高:
0.0900
开:
0.0900
低:
0.0840
收:
0.0900
52周最高:
0.1657
52周最低:
0.0425
股本:
4.55亿
流通股本:
4.34亿
量比:
0.59
换手率:
0.04%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.0069
每股收益(LYR):
-0.0043
净资产收益率:
-178.25%
总资产收益率:
-96.45%
市净率:
-5.58
市盈率(LYR):
-20.49
数据加载中...
总览
公司
新闻资讯
公告
Vivos Inc. 宣布在向FDA提交Radiogel®精准放射性核素疗法™研究器械豁免申请方面取得重大进展
美股速递
·
02/10
Vivos Inc.聘请顶级FDA监管专家约翰·J·史密斯博士支持Radiogel®的IDE提交
美股速递
·
2025/10/27
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠:港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投,免费实时行情与多种工具,立即开户享更多优惠!","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠:港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投,免费实时行情与多种工具,立即开户享更多优惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/RDGL/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"RDGL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RDGL\",,,,,undefined,":{"symbol":"RDGL","market":"US","secType":"STK","nameCN":"Vivos Inc.","latestPrice":0.088,"timestamp":1774285200000,"preClose":0.09,"halted":0,"volume":189854,"delay":15,"changeRate":-0.022222222222222244,"floatShares":434000000,"shares":454664957,"eps":-0.006898,"marketStatus":"交易中","change":-0.002,"latestTime":"03-23 13:00:00 EDT 延时","open":0.09,"high":0.09,"low":0.084,"amount":16691.27261144,"amplitude":0.066667,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.006898,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1774296000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.09,"volumeRatio":0.588108},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RDGL\",,,,,undefined,":{"symbol":"RDGL","floatShares":434000000,"roa":"-96.45%","roe":"-178.25%","lyrEps":-0.004295,"volumeRatio":0.588108,"shares":454664957,"dividePrice":0,"high":0.09,"amplitude":0.066667,"preClose":0.09,"low":0.084,"week52Low":0.0425,"pbRate":"-5.58","psRate":"822.89","week52High":0.1657,"institutionHeld":0,"latestPrice":0.088,"eps":-0.006898,"divideRate":0,"volume":189854,"delay":15,"ttmEps":-0.006898,"open":0.09,"prevYearClose":0.0689,"prevWeekClose":0.09,"prevMonthClose":0.0849,"prevQuarterClose":0.0689,"fiveDayClose":0.0866,"twentyDayClose":0.083,"sixtyDayClose":0.0689},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RDGL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-13","symbol":"RDGL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-08-13","symbol":"RDGL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-05-09","symbol":"RDGL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-03-18","symbol":"RDGL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1710734400000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2023-11-06","symbol":"RDGL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1699246800000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RDGL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RDGL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RDGL\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1172695555","title":"Vivos Inc. 宣布在向FDA提交Radiogel®精准放射性核素疗法™研究器械豁免申请方面取得重大进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1172695555","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172695555?lang=zh_cn&edition=fundamental","pubTime":"2026-02-10 21:33","pubTimestamp":1770730414,"startTime":"0","endTime":"0","summary":"Vivos Inc. 近日宣布,公司在为其核心产品Radiogel®精准放射性核素疗法™向美国食品药品监督管理局(FDA)提交研究器械豁免(IDE)申请的工作中,取得了显著进展。这一关键里程碑标志着该疗法向临床应用迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RDGL","BK4082"],"gpt_icon":0},{"id":"1185565667","title":"Vivos Inc.聘请顶级FDA监管专家约翰·J·史密斯博士支持Radiogel®的IDE提交","url":"https://stock-news.laohu8.com/highlight/detail?id=1185565667","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185565667?lang=zh_cn&edition=fundamental","pubTime":"2025-10-27 20:30","pubTimestamp":1761568217,"startTime":"0","endTime":"0","summary":"Vivos Inc.聘请顶级FDA监管专家约翰·J·史密斯博士,以支持Radiogel®的IDE提交。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","RDGL"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}